$ARWR 4 SEC Filings

Filed On	Filing
20 Aug 2026	Form 4: Olukotun Adeoye Y, Director Sold 2,000 shares ($174K)
20 Aug 2026	Form 4: Perry Michael S, Director Sold 11,600 shares ($1.01M)
17 Jun 2026	Form 4: Cohen Matthew Gregory, Director Received 11,882 shares as a grant or award
14 May 2026	Form 4: Lu Hongbo, Director Sold 2,970 shares ($228K)
24 Apr 2026	Form 4: Apel Daniel Joseph, Chief Financial Officer Sold 13,095 shares ($934K)
24 Apr 2026	Form 4: Hamilton James C, Chief Medical Officer Sold 10,000 shares ($750K)
09 Mar 2026	Form 4: Hamilton James C, Chief Medical Officer Sold 10,000 shares ($642K)
08 Jan 2026	Form 4: Hamilton James C, Chief Medical Officer Received 75,000 shares as a grant or award
08 Jan 2026	Form 4: Apel Daniel Joseph, Chief Financial Officer Received 75,000 shares as a grant or award
08 Jan 2026	Form 4: O'Brien Patrick, COO Gave 2,500 shares as a gift · Received 75,000 shares as a grant or award
05 Jan 2026	Form 4: Hamilton James C, Chief Medical Officer Sold 40,164 shares ($2.53M)
05 Jan 2026	Form 4: O'Brien Patrick, COO Gave 2,800 shares as a gift · Sold 49,493 shares ($3.12M)
05 Jan 2026	Form 4: Anzalone Christopher Richard, Director Sold 13,187 shares ($872K)
30 Dec 2025	Form 4: Anzalone Christopher Richard, Director Received 51,726 shares by exercise or conversion ($318K) · Sold 51,726 shares ($3.58M)
30 Dec 2025	Form 4: Ferrari Mauro, Director Sold 7,530 shares ($527K)
23 Dec 2025	Form 4: Waddill William D., Director Sold 8,367 shares ($566K)
23 Dec 2025	Form 4: Vakiener Victoria, Director Sold 10,040 shares ($679K)
23 Dec 2025	Form 4: Anzalone Christopher Richard, Director Sold 13,445 shares ($910K) · Sold 12,586 shares ($861K)
23 Dec 2025	Form 4: Olukotun Adeoye Y, Director Sold 10,000 shares ($677K)
19 Dec 2025	Form 4: Anzalone Christopher Richard, Director Sold 85,000 shares ($5.44M)

Comments